PeyserTA, NakamuraK, PriceD, et al.: Hypoglycemic accuracy and improved low glucose alerts of the latest Dexcom G4 Platinum continuous glucose monitoring system. Diabetes Technol Ther, 2015:17:548–554.
2.
AmielSA, SherwinRS, SimonsonDC, et al.: Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release. Diabetes, 1988; 37:901–907.
3.
AmielSA, TamborlaneWV, SimonsonDC, et al.: Defective glucose counterregulation after strict glycemic control of insulin-dependent diabetes mellitus. N Engl J Med, 1987; 316:1376–1383.
4.
CryerPE, GerichJE: Glucose counterregulation, hypoglycemia, and intensive therapy of diabetes mellitus. N Engl J Med, 1985; 313:232–241.
5.
WhiteNH, SkorDA, CryerPE, et al.: Identification of type I diabetic patients at increased risk for hypoglycemia during intensive therapy. N Engl J Med, 1983; 308:485–491.
6.
The Diabetes Control and Complications Trial Research Group: Hypoglycemia in the Diabetes Control and Complications Trial. Diabetes, 1997; 46:271–286.
7.
CryerPE: Iatrogenic hypoglycemia as a cause of hypoglycemia-associated autonomic failure in IDDM: a vicious cycle. Diabetes, 1992; 41:255–260.
8.
CryerPE: Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes. Diabetologia, 2002; 45:937–948.
9.
WeinstockRS, XingD, MaahsDM, et al.: Severe hypoglycemia and diabetic ketoacidosis in adults with type 1 diabetes: results from the T1D Exchange clinic registry. J Clin Endocrinol Metab, 2013; 98:3411–3419.
10.
LyTT, HewittJ, DaveyRJ, et al.: Improving epinephrine responses in hypoglycemia unawareness with real-time continuous glucose monitoring in adolescents with type 1 diabetes. Diabetes Care, 2011; 34:50–52.
11.
ChoudharyP, RamasamyS, GreenL, et al.: Real-time continuous glucose monitoring significantly reduces severe hypoglycemia in hypoglycemia-unaware patients with type 1 diabetes. Diabetes Care, 2013; 36:4160–4162.
12.
BergenstalRM, KlonoffDC, GargSK, et al.: Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med, 2013; 369:224–232.
13.
BuckinghamBA, CameronF, CalhounP, et al.: Outpatient safety assessment of an in-home predictive low-glucose suspend system with type 1 diabetes subjects at elevated risk of nocturnal hypoglycemia. Diabetes Technol Ther, 2013; 15:622–627.
14.
PhillipM, BattelinoT, AtlasE, et al.: Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med, 2013; 368:824–833.
15.
HovorkaR, ElleriD, ThabitH, et al.: Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care, 2014; 37:1204–1211.
16.
KovatchevBP, RenardE, CobelliC, et al.: Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas. Diabetes Care, 2014; 37:1789–1796,.
17.
LyTT, BretonMD, Keith-HynesP, et al.: Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp. Diabetes Care, 2014; 37:37:2310–2316.
18.
BrownSA, KovatchevBP, BretonMD, et al.: Multinight “bedside” closed-loop control for patients with type 1 diabetes. Diabetes Technol Ther, 2015; 17:203–209.
19.
RebrinK, SteilGM, van AntwerpWP, et al.: Subcutaneous glucose predicts plasma glucose independent of insulin: implications for continuous monitoring. Am J Physiol Endocrinol Metab, 1999; 277:E561–E571.
20.
AussedatB, Dupire-AngelM, GiffordR, et al.: Interstitial glucose concentration and glycemia: implications for continuous subcutaneous glucose monitoring. Am J Physiol Endocrinol Metab, 2000; 278:E716–E728.
21.
SteilGM, RebrinK, HaririF, et al.: Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia. Diabetologia, 2005; 48:1833–1840.
22.
KingCR, AndersonSM, BretonMD, et al.: Modeling of calibration effectiveness and blood-to-interstitial glucose dynamics as potential confounders of the accuracy of continuous glucose sensors during hyperinsulinemic clamp. J Diabetes Sci Technol, 2007; 1:317–322.
23.
KovatchevBP, ClarkeWL: Peculiarities of the continuous glucose monitoring data stream and their impact on developing closed-loop control technology. J Diabetes Sci Technol, 2008; 2:158–163.
24.
FacchinettiA, SparacinoG, GuerraS, et al.: Real-time improvement of continuous glucose monitoring accuracy: the smart sensor concept. Diabetes Care, 2013; 36:793–800.
25.
GarciaA, Rack-GomerAL, BhavarajuNC, et al.: Dexcom G4AP: an advanced continuous glucose monitor for the artificial pancreas. J Diabetes Sci Technol, 2013; 7:1436–1445.
26.
BaileyTS, ChangA, ChristiansenM: Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm. J Diabetes Sci Technol, 2014; 9:209–214.
27.
PickupJC, Ford HollowayM, SamsiK: Real-time continuous glucose monitoring in type 1 diabetes: a qualitative framework analysis of patient narratives. Diabetes Care, 2015; 38:544–550.
28.
KovatchevBP, PatekSD, OrtizEA, et al.: Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring. Diabetes Technol Ther, 2015; 17:177–186.
29.
PolonskyWH, HesslerD: Perceived accuracy in continuous glucose monitoring: understanding the impact on patients. J Diabetes Sci Technol, 2015; 9:339–341.
